Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-08-02

Clinical Trial Update: Study to Evaluate the Safety and Pharmacokinetics of Single Doses of ASP2151 in Healthy Male Subjects and the Effects of Food [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the safety, pharmacokinetics, and the effect of food on single doses of ASP2151 in healthy male subjects; the trial relates to genital …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ASP2151

Snippet

Sponsor: Astellas Pharma Europe Ltd. | Conditions: Herpes Genitalis, Herpes Zoster | Phase 1 | Status: COMPLETED